RenBio Email Format
Biotechnology ResearchNew York, United States2-10 Employees
RenBio is a biotechnology research company focused on developing antibody-based therapeutics and an antibody delivery platform. The organization aims to broaden access to antibody treatments by addressing manufacturing and delivery challenges that can limit practical use of these therapies. Based in New York City, RenBio has roots tied to prominent scientists and institutions and operates within the biotechnology research sector, pursuing early-stage development and translation of its approaches. The company has been recognized in the industry for its potential and collaborators include major funders, situating it among early-stage biotech firms aiming to advance next-generation antiviral antibody therapeutics. Recent activity indicates ongoing work to advance its antibody delivery system, reflecting its objective of transforming the deployment of antibody treatments.